Health ❯ Healthcare ❯ Obesity

Weight Loss

Medications GLP-1 Medications GLP-1 Drugs Pharmaceuticals Mounjaro Weight Loss Drugs Weight Loss Injections Medication GLP-1 Receptor Agonists Prescription Drugs

Study Links GLP-1 Drugs to Lower Death and Recurrence in Breast Cancer

Experts urge randomized trials before any change in breast cancer care.

High-Dose Wegovy Delivers Larger Fat Loss as Lilly Pill Maintains It, New Trials Show

Trial Hints ‘Gut Reset’ May Slow Weight Regain After Stopping GLP‑1 Drugs

India’s Generic Semaglutide Wave Eats Into Mounjaro’s Lead as Novo Holds Share

Mexico Renews Warning as Counterfeit GLP-1 Weight-Loss Drugs Spread Worldwide

India Braces for 50+ Semaglutide Generics as Patent Expires Friday

Most Weight Lost on GLP-1 Drugs Returns After Stopping, New Analysis Finds

Private GLP-1 Weight-Loss Use in UK Skews to Middle-Class Women, Analysis Shows

Ramadan Fasting: Doctors Urge Stable GLP-1 Use, Warn Against Starting or Raising Doses

GLP-1 Era Hits the Mainstream With Super Bowl Ads as Costs Rise and Care Shifts to Maintenance

Oxford BMJ Review Finds Rapid Weight Rebound After Stopping Modern Weight-Loss Drugs

Stopping Mounjaro Leads to Weight Regain and Reversed Health Gains, Study Finds

Lancet Phase 3 Trial Shows Oral GLP-1 Orforglipron Aids Weight Loss and Diabetes Control

Counterfeit ‘Ozempic’ Bought Online Puts Italian Woman in Coma, Prompting AIFA Investigation

Lilly to Launch Late-Stage Trials of Amylin Obesity Drug After 20% Weight Loss in Mid-Stage Study

Streeting Calls for NHS to Open Weight-Loss Jabs to Millions More

Bariatric Surgery Outperforms GLP-1 Medicines Over 10 Years for Patients With Diabetes and Obesity

UK Mounjaro Orders Frozen Ahead of Price Hike as Korea Confronts Soaring Wegovy Use

NICE Unveils Draft Overhaul of Type 2 Diabetes Care in England

Germany’s Bariatric Surgery Volumes Reach 26,250 in 2023